1
Total investments
1
Early stage
0
Mid stage
0
Late stage
6y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Early Investor, former Board Observer
Nov 2020
We are the first in class pre-clinical translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered targets.
Experience · 4 entries
All (4)
Investments (1)
Founder (1)
Board (1)
2023
Strategic Advisor
Jan 2023
The Ventures team invests in early-stage companies, connecting Exor back to its entrepreneurial roots and long history of innovation. The team focuses on discovering exceptional founders who have the ambition to build great companies.
2020
Early Investor, former Board Observer
Nov 2020
We are the first in class pre-clinical translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered targets.
2012
Founder
Nov 2012
An advisory company dedicated to deep tech entrepreneurship in Europe. Relentlessly focused on discovering ambitious talents in scientific and deep tech space.
2008
Principal - Investment Team
Mar 2008
Exor N.V. has been building great companies since its foundation by the Agnelli Family. For more than a century, Exor has made successful investments worldwide, applying a culture that combines entrepreneurial spirit and financial discipline. With a Net Asset Value of around EUR 36 billion, its portfolio is principally made up of companies in which Exor is the largest shareholder including Ferrari, Stellantis, CNH Industrial and Philips.